- Home
- FINV vs BHVN Comparison
FINV vs BHVN Comparison
Compare FINV & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINV
- BHVN
- Stock Information
- Founded
- FINV 2007
- BHVN 2013
- Country
- FINV China
- BHVN United States
- Employees
- FINV N/A
- BHVN N/A
- Industry
- FINV Finance: Consumer Services
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- FINV Finance
- BHVN Health Care
- Exchange
- FINV Nasdaq
- BHVN Nasdaq
- Market Cap
- FINV 1.9B
- BHVN 1.7B
- IPO Year
- FINV N/A
- BHVN 2017
- Fundamental
- Price
- FINV $7.09
- BHVN $15.31
- Analyst Decision
- FINV Strong Buy
- BHVN Strong Buy
- Analyst Count
- FINV 2
- BHVN 14
- Target Price
- FINV $11.55
- BHVN $49.23
- AVG Volume (30 Days)
- FINV 1.3M
- BHVN 2.4M
- Earning Date
- FINV 11-17-2025
- BHVN 11-11-2025
- Dividend Yield
- FINV 4.03%
- BHVN N/A
- EPS Growth
- FINV 32.63
- BHVN N/A
- EPS
- FINV 1.49
- BHVN N/A
- Revenue
- FINV $1,927,901,951.00
- BHVN N/A
- Revenue This Year
- FINV $11.56
- BHVN N/A
- Revenue Next Year
- FINV $8.06
- BHVN $2,195.07
- P/E Ratio
- FINV $4.94
- BHVN N/A
- Revenue Growth
- FINV 7.84
- BHVN N/A
- 52 Week Low
- FINV $5.72
- BHVN $12.79
- 52 Week High
- FINV $11.08
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- FINV 35.19
- BHVN 52.61
- Support Level
- FINV $7.09
- BHVN $14.32
- Resistance Level
- FINV $7.65
- BHVN $16.24
- Average True Range (ATR)
- FINV 0.25
- BHVN 0.87
- MACD
- FINV -0.00
- BHVN 0.14
- Stochastic Oscillator
- FINV 9.78
- BHVN 63.91
About FINV FinVolution Group
FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.